Clinical Trial Update: Intermittent Versus Continuous Infusion Meropenem in Cystic Fibrosis

View source ↗

Summary

A clinical trial evaluating intermittent versus continuous infusion of meropenem in cystic fibrosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Meropenem (Meropenem)

Snippet

Sponsor: Dayton Children's Hospital | Conditions: Cystic Fibrosis | Status: WITHDRAWN